Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2010
09/10/2010WO2010101220A1 Novel enzymes and dna encoding same
09/10/2010WO2010101158A1 Novel gene derived from clostridium cellulovorans and use thereof
09/10/2010WO2010101129A1 Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factors
09/10/2010WO2010101119A1 Cell mass derived from cancer tissue and process for preparing same
09/10/2010WO2010100878A1 Vangl1 peptides and vaccines including the same
09/10/2010WO2010100831A1 Methyltransferase enzyme
09/10/2010WO2010100615A1 Device for diagnosis of physiologic status and/or selection of the best spermatozoa of a semen sample based on chemotaxis, and procedure of use thereof
09/10/2010WO2010100346A1 Plants of genus diplotaxis having male cytoplasmic sterility
09/10/2010WO2010100150A1 Method for increasing the pool of ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass
09/10/2010WO2010099962A1 Soluble poly (amido-amines) useful as promoters of cell adhesion, proliferation and differentiation
09/10/2010WO2010099955A1 Protease for wound conditioning and skin care
09/10/2010WO2010099643A1 Method for promoting somatic cells proliferation
09/10/2010WO2010099612A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010WO2010099589A1 Method for modifying bovine embryo stem cells and method for purifying proteins produced by modified bovine embryo stem cells
09/10/2010WO2010099576A1 Compositions and methods for enhancing immune responses
09/10/2010WO2010083162A3 Unc-45a splice variants based cancer diagnostics and therapeutics
09/10/2010WO2010075510A9 Large scale pancreatic islet purification
09/10/2010CA2791425A1 Microbial production of 3-hydroxyacids from glucose and glycolate
09/10/2010CA2754065A1 Methods of inhibiting photoreceptor apoptosis
09/10/2010CA2754044A1 Protease for wound conditioning and skin care
09/10/2010CA2753681A1 Vangl1 peptides and vaccines including the same
09/10/2010CA2753621A1 Antibodies and epitopes specific to misfolded prion protein
09/10/2010CA2753616A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
09/10/2010CA2753526A1 A cancer tissue-derived cell mass and a process for preparing same
09/10/2010CA2752267A1 Method for increasing the pool of ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass
09/09/2010US20100229261 Novel brassica plants
09/09/2010US20100229260 Optimized t-dna transfer and vectors therefor
09/09/2010US20100229259 Plants having improved growth characteristics and method for making the same
09/09/2010US20100229253 Characterization of the i-spomi endonuclease from fission yeast
09/09/2010US20100229252 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
09/09/2010US20100228007 Mhc-peptide complex binding ligands
09/09/2010US20100227915 Compositions and methods for inhibiting expression of a gene from the jc virus
09/09/2010US20100227910 Gene fusion targeted therapy
09/09/2010US20100227902 Bis-aryl sulfonamides
09/09/2010US20100227802 Methods and materials relating to PAQR polypeptides and polynucleotides
09/09/2010US20100227793 Compositions and Methods for Treating Amyotrophic Lateral Sclerosis
09/09/2010US20100227405 Methods of using multilayered cell culture apparatus
09/09/2010US20100227404 Water extract of antrodia camphorata for immunostimulatory effect and preparation method thereof
09/09/2010US20100227403 rbLIF PROTEIN FOR USE IN EMBRYONIC STEM CELL CULTURES
09/09/2010US20100227402 Cell Surface Coating with Hyaluronic Acid Oligomer Derivative
09/09/2010US20100227401 Media and processes for the ex vivo production of megakaryocytes from human cd34+ cells
09/09/2010US20100227400 Monomeric and dimeric fluorescent protein variants and methods for making same
09/09/2010US20100227399 Soft gel systems in modulating stem cell development
09/09/2010US20100227398 Method for Mixing Object into Gelled Assembly
09/09/2010US20100227397 Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles
09/09/2010US20100227396 Embryonic Stem Cell-Like Cells
09/09/2010US20100227395 Canine tumor cell and allogeneic dendritic cell fused vaccine and method for preparing the same
09/09/2010US20100227394 Fusion antibodies
09/09/2010US20100227393 Liver stem cells: isolation of hepatic progenitor cells from the human gall bladder
09/09/2010US20100227392 Use of RPA32, RPA4, and RPA4/RPA32 Hybrid Polypeptides and Polynucleotides for Assessing and Modulating Cell Proliferation
09/09/2010US20100227375 Polypeptides Having Lipase Activity and Polynucleotides Encoding Same
09/09/2010US20100227363 Alg3 mutant
09/09/2010US20100227358 Mineralized three-dimensional bone constructs
09/09/2010US20100227357 Fungal isolates and their use to confer salinity and drought tolerance in plants
09/09/2010US20100227343 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
09/09/2010US20100227339 Differential immunoassay for prrs vaccine antibody
09/09/2010US20100227335 Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer
09/09/2010US20100227330 Methods for diagnosing episodic movement disorders and related conditions
09/09/2010US20100227319 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets
09/09/2010US20100227311 Tissue culture system for production of hepatitis c virus
09/09/2010US20100227307 Ergothioneine and/or its derivatives as a cell preservative
09/09/2010US20100226976 Encapsulated mesenchymal stem cells and uses thereof
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/09/2010US20100226956 Production of moldable bone substitute
09/09/2010US20100226934 Circovirus sequences associated with piglet weight loss disease (pwd)
09/09/2010US20100226930 Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies to EphA3
09/09/2010US20100226929 Direct Oxidation of Calcium/Calmodulin Dependent Protein Kinase II and Associated Diagnostic and Therapeutic Methods
09/09/2010US20100226925 Homogeneous Antibody Populations
09/09/2010US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides
09/09/2010US20100226915 AGER-Peptides and Use Thereof
09/09/2010US20100226912 RECOMBINANT PROTEIN PRODUCTION IN AVIAN EBx® CELLS
09/09/2010US20100226906 Recombinant poly-glutamic acid depolymerases
09/09/2010US20100226901 Genetic control of mammalian cells with synthetic rna regulatory systems
09/09/2010US20100226898 Compositions and methods for engraftment and increasing survival of adult muscle stem cells
09/09/2010US20100226895 Neural scaffolds
09/09/2010US20100226888 Ethanol Enhances the Complete Replication of Hepatitis C Virus: the Role of Acetaldehyde
09/09/2010US20100226887 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
09/09/2010US20100226884 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
09/09/2010US20100226856 Dynamic bio-nanoparticle elements
09/09/2010US20100226854 MHC Peptide Complexes and Uses Thereof in Infectious Diseases
09/09/2010DE112008001609T5 Reparatur und Behandlung von Knochendefekten unter Verwendung von mittels einem Wirkstoff induzierten Zellen, der von hypertrophierungsfähigen Chondrozyten hergestellt wird, und eines Gerüsts Repair and treat bone defects using an active substance-induced cells, which is manufactured by hypertrophierungsfähigen chondrocytes, and a scaffold
09/09/2010DE102009053519A1 Obtaining autologous cells, useful e.g. to prepare tissues for transplantation, comprises obtaining mesenchymal stem cells from body, and differentiating stem cells into tissue-/tissue forming-progenitor cells using differentiation medium
09/08/2010EP2226739A1 Method for the evolutionary design of biochemical reaction networks
09/08/2010EP2226385A1 Human Coagulation Factor VII Variants
09/08/2010EP2226383A1 Novel atp:citrate lyase genes
09/08/2010EP2226382A1 Protease for wound conditioning and skin care
09/08/2010EP2226381A1 Method for cultivating cells for the production of compounds
09/08/2010EP2225389A1 Sm-protein based secretion engineering
09/08/2010EP2225365A1 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells
09/08/2010EP2225363A1 Method for reprogramming in vitro stem cells and somatic cells into germinal cells
09/08/2010EP2225362A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
09/08/2010EP2225361A1 Bioengineered tissue constructs and methods for production and use
09/08/2010EP2224934A1 Human bone-forming cells in the treatment of inflammatory rheumatic diseases
09/08/2010EP1963489B1 Multiloop engineered heart muscle tissue
09/08/2010EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof
09/08/2010EP1478667B1 Anti-human tenascin monoclonal antibody
09/08/2010EP1429797B1 Diagnosis and treatment of malignant neoplasms
09/08/2010EP1412374B1 Novel pgc-1 isoforms and uses therefor
09/08/2010EP1371731B1 Aminoketone asymmetric reductase and nucleic acid thereof
09/08/2010CN1995063B Plant sulfur highly effective exploitation protein and its coding gene and application
1 ... 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 ... 1827